Medicine ClinicalPharmacology Foundations: ADME and Dose-Response
Atlas the guide stands beside a glowing transparent body model, tracing a bright pill's path from mouth to gut wall to liver to bloodstream to tissues to kidney, with a dose-response curve chalked on a blackboard behind.
- Define the four classical pharmacokinetic stages — absorption, distribution, metabolism, and excretion — and state a key route for each.
- Distinguish pharmacokinetics (what the body does to a drug) from pharmacodynamics (what a drug does to the body).
- Interpret a dose-response curve to explain how increasing dose relates to effect and receptor saturation.
- Explain how oral first-pass hepatic metabolism differs from the simplified ADME sequence and why it matters clinically.
- Explain how ADME and dose-response together guide drug selection and dosing decisions.
Key terms
- Pharmacokinetics
- What the body does to a drug across absorption, distribution, metabolism, excretion
- Pharmacodynamics
- What the drug does to the body through receptor effects
- First-pass metabolism
- Hepatic processing of oral drug before reaching systemic circulation
- Therapeutic window
- The dose range between a helpful and a harmful effect
ADME and the First-Pass Nuance
Pharmacokinetics is captured by ADME: absorption into the bloodstream, distribution to tissues, metabolism that chemically transforms the drug mainly in the liver, and excretion that removes it primarily via the kidneys but often via bile and feces too. The classical absorption-then-distribution-then-metabolism-then-excretion order is a teaching simplification that holds best for intravenous drugs. For oral drugs, absorbed molecules travel through the portal vein to the liver first, so substantial first-pass metabolism occurs before distribution completes, which lowers the bioavailable dose reaching circulation.
Dose-Response and the Therapeutic Window
Pharmacodynamics describes how a drug acts on receptors like a key in a lock to turn a biological signal up or down. A dose-response curve shows effect rising with dose then plateauing once receptors are saturated, because adding more drug cannot recruit receptors that are already occupied. Too little produces no useful effect and too much causes toxicity, so clinicians aim for the therapeutic window. When a drug clears slowly, as with renally cleared aminoglycosides in kidney impairment, the dose or interval must be adjusted to avoid accumulating to toxic levels.
Worked examples
Adjust dosing for reduced kidney function
- Recognize gentamicin is an aminoglycoside eliminated almost entirely by renal clearance.
- Note the patient has reduced kidney function, so clearance is slower than normal.
- Predict that unchanged dosing would let the drug accumulate, pushing concentration above the therapeutic window toward nephrotoxic or ototoxic levels.
- Choose to reduce the dose or extend the dosing interval to keep concentration within the safe range.
Answer: Reduce the dose or lengthen the interval to prevent toxic accumulation of the renally cleared drug.
Activity
Arrange the four stages in the classical (simplified) textbook sequence for pharmacokinetics — note that for oral drugs, first-pass metabolism partially overlaps with early distribution
Practice
Arrange absorption, distribution, metabolism, and excretion into the classical pharmacokinetic sequence.
Explain why a dose-response curve plateaus once the drug saturates its receptors.
Common mistakes to avoid
- Increasing dose always increases effect indefinitelyEffect plateaus once receptors are saturated, and excess dose only adds toxicity.
- Excretion route never affects therapeutic dosingA slowly cleared drug accumulates, so impaired clearance demands a reduced dose or interval.
Check your understanding
In pharmacokinetics, which stage describes a drug entering the bloodstream after being swallowed?
Which statement correctly describes pharmacodynamics versus pharmacokinetics?
On a dose-response curve, what happens to the therapeutic effect as the dose keeps increasing past the point where receptors are saturated?
A patient is prescribed gentamicin, an aminoglycoside antibiotic that is eliminated almost entirely by renal (kidney) clearance. If this patient has reduced kidney function, what dosing adjustment is most appropriate?
Recap
Pharmacokinetics describes ADME, what the body does to a drug, with oral drugs undergoing first-pass hepatic metabolism before distribution, while pharmacodynamics describes receptor effects and the dose-response curve that plateaus at saturation; together they guide drug selection and dosing within the therapeutic window.
Reflect
Why does understanding clearance change how you would dose a drug in kidney disease?